SK285820B6 - Polymorfné formy kryštalického azabicyklo[2.2.2]oktán-3-amín- citrátu a farmaceutické kompozície s ich obsahom - Google Patents

Polymorfné formy kryštalického azabicyklo[2.2.2]oktán-3-amín- citrátu a farmaceutické kompozície s ich obsahom Download PDF

Info

Publication number
SK285820B6
SK285820B6 SK1733-2001A SK17332001A SK285820B6 SK 285820 B6 SK285820 B6 SK 285820B6 SK 17332001 A SK17332001 A SK 17332001A SK 285820 B6 SK285820 B6 SK 285820B6
Authority
SK
Slovakia
Prior art keywords
polymorphic form
citrate monohydrate
crystalline
octan
hours
Prior art date
Application number
SK1733-2001A
Other languages
English (en)
Slovak (sk)
Other versions
SK17332001A3 (sk
Inventor
Michael James Castaldi
George Joseph Quallich
Lewin Theophilus Wint
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of SK17332001A3 publication Critical patent/SK17332001A3/sk
Publication of SK285820B6 publication Critical patent/SK285820B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Otolaryngology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SK1733-2001A 1999-06-01 2000-05-18 Polymorfné formy kryštalického azabicyklo[2.2.2]oktán-3-amín- citrátu a farmaceutické kompozície s ich obsahom SK285820B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13699299P 1999-06-01 1999-06-01
PCT/IB2000/000665 WO2000073304A1 (en) 1999-06-01 2000-05-18 Polymorphs of a crystalline azabicyclo (2,2,2) octan-3-amine citrate and their pharmaceutical compositions

Publications (2)

Publication Number Publication Date
SK17332001A3 SK17332001A3 (sk) 2002-07-02
SK285820B6 true SK285820B6 (sk) 2007-09-06

Family

ID=22475338

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1733-2001A SK285820B6 (sk) 1999-06-01 2000-05-18 Polymorfné formy kryštalického azabicyklo[2.2.2]oktán-3-amín- citrátu a farmaceutické kompozície s ich obsahom

Country Status (49)

Country Link
US (1) US6255320B1 (ru)
EP (1) EP1181290B1 (ru)
JP (1) JP3830816B2 (ru)
KR (1) KR100476606B1 (ru)
CN (1) CN1146565C (ru)
AP (1) AP2001002349A0 (ru)
AR (1) AR033331A1 (ru)
AT (1) ATE244239T1 (ru)
AU (1) AU767334B2 (ru)
BG (1) BG65240B1 (ru)
BR (1) BR0011094A (ru)
CA (1) CA2372238C (ru)
CO (1) CO5170463A1 (ru)
CY (1) CY2007011I2 (ru)
CZ (1) CZ295819B6 (ru)
DE (1) DE60003679T2 (ru)
DK (1) DK1181290T3 (ru)
DZ (1) DZ3050A1 (ru)
EA (1) EA003731B1 (ru)
EC (1) ECSP003508A (ru)
EE (1) EE200100656A (ru)
ES (1) ES2199825T3 (ru)
GT (1) GT200000087A (ru)
HK (1) HK1046284A1 (ru)
HN (1) HN2000000077A (ru)
HR (1) HRP20010904A2 (ru)
HU (1) HUP0201301A3 (ru)
IL (1) IL146406A0 (ru)
MA (1) MA26742A1 (ru)
MX (1) MXPA01012325A (ru)
MY (1) MY133508A (ru)
NO (1) NO20015848L (ru)
NZ (1) NZ515349A (ru)
OA (1) OA11956A (ru)
PA (1) PA8496101A1 (ru)
PE (1) PE20010209A1 (ru)
PL (1) PL196046B1 (ru)
PT (1) PT1181290E (ru)
SI (1) SI1181290T1 (ru)
SK (1) SK285820B6 (ru)
SV (1) SV2001000093A (ru)
TN (1) TNSN00120A1 (ru)
TR (1) TR200103473T2 (ru)
TW (1) TWI285204B (ru)
UA (1) UA66925C2 (ru)
UY (1) UY26176A1 (ru)
WO (1) WO2000073304A1 (ru)
YU (1) YU81101A (ru)
ZA (1) ZA200109775B (ru)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1913893A (zh) * 2004-01-30 2007-02-14 辉瑞产品有限公司 改善麻醉恢复的nk－1受体拮抗剂
PT1713504T (pt) * 2004-01-30 2017-08-29 Zoetis Services Llc Conservantes antimicrobianos para obter uma formulação multidose utilizando beta-ciclodextrinas para formas galénicas líquidas
MXPA06008648A (es) * 2004-01-30 2006-09-04 Pfizer Prod Inc Composiciones farmaceuticas de antagonistas del receptor de neuroquinina y ciclodextrina y metodos para una tolerancia mejorada en el sitio de inyeccion.
RU2320659C9 (ru) * 2004-02-02 2008-07-20 Пфайзер Продактс Инк. Способы получения 1-(2s, 3s)-2-бензгидрил-n-(5-трет-бутил-2-метоксибензил)хинуклидин-3-амина в виде камфорсульфатной соли, цитратной соли и свободного основания и промежуточное соединение
JP6454323B2 (ja) * 2013-03-15 2019-01-16 パール セラピューティクス，インコーポレイテッド 粒子状結晶性材料のコンディショニングのための方法及びシステム
CN110577522B (zh) * 2018-06-07 2022-12-27 东莞市东阳光动物保健药品有限公司 马罗匹坦柠檬酸盐新晶型及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA27776C2 (ru) * 1991-05-31 2000-10-16 Пфайзер Інк. Производные хинуклидина и их фармацевтически приемлемые соли, которые являются антагонистами вещества р у млекопитающих, фармацевтическая композиция, имеющая антагонистическое действие на вещество р у млекопитающих
US5393762A (en) * 1993-06-04 1995-02-28 Pfizer Inc. Pharmaceutical agents for treatment of emesis
US5576317A (en) * 1994-12-09 1996-11-19 Pfizer Inc. NK-1 receptor antagonists and 5HT3 receptor antagonists for the treatment of emesis

Also Published As

Publication number Publication date
ECSP003508A (es) 2002-02-25
CY2007011I1 (el) 2010-07-28
HRP20010904A2 (en) 2003-02-28
CZ20014269A3 (cs) 2002-04-17
YU81101A (sh) 2004-07-15
GT200000087A (es) 2001-11-22
CN1353711A (zh) 2002-06-12
UY26176A1 (es) 2000-12-29
IL146406A0 (en) 2002-07-25
BG65240B1 (bg) 2007-09-28
KR100476606B1 (ko) 2005-03-18
DE60003679D1 (de) 2003-08-07
HUP0201301A2 (en) 2002-08-28
DZ3050A1 (fr) 2004-03-27
TNSN00120A1 (fr) 2005-11-10
US6255320B1 (en) 2001-07-03
CA2372238C (en) 2006-12-19
ES2199825T3 (es) 2004-03-01
AR033331A1 (es) 2003-12-17
PL196046B1 (pl) 2007-11-30
SK17332001A3 (sk) 2002-07-02
DE60003679T2 (de) 2004-05-27
PE20010209A1 (es) 2001-03-01
HN2000000077A (es) 2001-02-02
EP1181290A1 (en) 2002-02-27
KR20020010688A (ko) 2002-02-04
AP2001002349A0 (en) 2001-12-31
CO5170463A1 (es) 2002-06-27
NO20015848L (no) 2001-12-18
EP1181290B1 (en) 2003-07-02
AU767334B2 (en) 2003-11-06
MA26742A1 (fr) 2004-12-20
PT1181290E (pt) 2003-09-30
WO2000073304A1 (en) 2000-12-07
HK1046284A1 (en) 2003-01-03
OA11956A (en) 2006-04-13
TWI285204B (en) 2007-08-11
EA003731B1 (ru) 2003-08-28
MXPA01012325A (es) 2002-07-22
CZ295819B6 (cs) 2005-11-16
HUP0201301A3 (en) 2002-10-28
AU4424800A (en) 2000-12-18
SV2001000093A (es) 2001-11-08
DK1181290T3 (da) 2003-09-29
TR200103473T2 (tr) 2002-04-22
PA8496101A1 (es) 2002-07-30
NZ515349A (en) 2004-03-26
EE200100656A (et) 2003-02-17
MY133508A (en) 2007-11-30
NO20015848D0 (no) 2001-11-30
ATE244239T1 (de) 2003-07-15
ZA200109775B (en) 2002-11-28
CA2372238A1 (en) 2000-12-07
BR0011094A (pt) 2002-03-19
JP3830816B2 (ja) 2006-10-11
EA200101108A1 (ru) 2002-04-25
PL352716A1 (en) 2003-09-08
UA66925C2 (ru) 2004-06-15
CN1146565C (zh) 2004-04-21
CY2007011I2 (el) 2010-07-28
JP2003501354A (ja) 2003-01-14
SI1181290T1 (en) 2003-12-31
BG106204A (en) 2002-07-31

Similar Documents

Publication Publication Date Title
SK282805B6 (sk) Monohydrát hydrochloridu 1-cyklopropyl-7-([S,S]-2,8- diazabicyklo[4,3,0]non-8-yl)-6-fluór-1,4-dihydro-8-metoxy-4-oxo- 3-chinolínkarboxylovej kyseliny
SK285820B6 (sk) Polymorfné formy kryštalického azabicyklo[2.2.2]oktán-3-amín- citrátu a farmaceutické kompozície s ich obsahom
MXPA02000033A (es) Polimorfos de un diclorhidrato cristalino de azobiciclo (2, 2, 2)oct-3-ilamina y sus composiciones farmaceuticas.
US6387925B1 (en) Polymorphs of a crystalline azo-bicyclo (2.2.2) oct-3-yl amine citrate and their pharmaceutical compositions
SK152095A3 (en) Crystalline (+) l-hydrogentartrate, preparation method thereof, pharmaceutical composition containing its and its use
CZ295578B6 (cs) Modifikovaná forma hydrochloridu R(-)-N-(4,4-di(3-methylthien-2-yl)but-3-enyl)nipekotové kyseliny, způsob její přípravy a použití a farmaceutické prostředky ji obsahující
US7001886B2 (en) Hot melt method for preparing diphenhydramine tannate
CZ203696A3 (en) Dimaleate of n,n-diethyl-8,8-dipropyl-2-azaspiro£4,5|decane-2-propanamine, pharmaceutical composition containing thereof and the use of such compound
SK15902000A3 (sk) 10-gáforsulfonát paroxetínu, spôsob jeho výroby a jeho použitie
SE455373B (sv) Anvendning av 1-(4-amino-6,7-dimetoxi-2-kinazolinyl)-4-(2-tetrahydrofuroyl)piperazinhydroklorid-dihydrat for framstellning av ett lekemedel

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20100518